Picture of Arcellx logo

ACLX Arcellx Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Arcellx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-18-32.1-65-189-70.7
Depreciation
Non-Cash Items0.1361.056.9783.650.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.261.752.724.45225
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-18.8-28.7-54.2-99.3208
Capital Expenditures-3.83-0.888-5.78-2.28-21.4
Purchase of Fixed Assets
Other Investing Cash Flow Items-74.2-115-133
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-3.83-0.888-80-118-155
Financing Cash Flow Items0.086-1.19-0.6880
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities42.741.7118253279
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2012.1-15.835.6332